European Journal of Biomedical and Pharmaceutical Sciences

FEMALE GENITAL SCHISTOSOMIASIS (FGS) IN S. HAEMATOBIUMIN INFECTION: A REVIEW

Nwosu,D.C., Obeagu,Emmanuel Ifeanyi, Nwanjo,H.U, Ogomaka,A.I.,Kanu,Stella
Ngozika, Okpara,K.E., Nwachukwu P.C., Avoaja D.A., Ajero C,M.U., Opara A.U., Nnorom R.M.

ABSTRACT

Female genital schistosomiasis is characterized by the occurrence of schistosome ova or worms in the upper and or lower genital tracts. However, morbidity caused by this phenomenon has received little or no attention from researchers and the scientific community for a long time now. This much was acknowledged by WHO which in 1997 through the gender task force of its tropical Disease Research Programme (TDK) included FGS among scientific areas deserving high research priority. So far evidence of the morbidity associated with this disease entity is supported mainly by Clinical observations as valid immunological and or field epidemiological data are still lacking. This is made worse by the fact that diagnosis of FGS of the upper genital tract has been incidental. This paper therefore, discusses FGS, highlighting its public health implications, need for increased global attention and the importance of according high research priority to this disease entity.

Keywords: Female genital schistosomiasis, Clinical observations, valid immunological.